Preclinical Data Shows Potential of Murepavadin Against P. Aeruginosa - Bronchiectasis News Today
Preclinical Data Shows Potential of Murepavadin Against P. Aeruginosa Bronchiectasis News Today
Preclinical data suggest that the experimental antibiotic murepavadin is both safe and effective at fighting restistant bacterial lung infections.
Comments
Post a Comment